[email protected] +91 9789129171
ICHKDM · Registering as Listener

International Conference on Hypertensive Kidney Disease and Management

4 - 5 Mar 2027 Mutare, Zimbabwe Standard / Physical Participation
Listener Registration
$120
virtual · $135 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICHKDM
ModeStandard / Physical
ParticipationListener
Registration fee$135.00
Bank charges (5.8%)$7.83
Total payable$142.83
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICHKDM conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 2 - Zero Hunger SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure
01 Pathophysiology of Hypertensive Kidney Disease +
This session will explore the underlying mechanisms that contribute to hypertensive kidney disease, focusing on the interplay between hypertension and renal function. Researchers will present findings on vascular changes, glomerular injury, and the role of inflammation in disease progression.
02 Innovations in Blood Pressure Management +
This track will highlight recent advancements in the management of blood pressure among patients with kidney disease. Discussions will include novel pharmacological therapies, lifestyle interventions, and the use of technology in monitoring and treatment.
03 Renal Function Assessment Techniques +
Participants will examine various methodologies for assessing renal function in hypertensive patients, including traditional and emerging biomarkers. The session aims to enhance understanding of how these techniques can inform clinical decision-making.
04 Cardiovascular Implications of Kidney Disease +
This session will delve into the cardiovascular risks associated with hypertensive kidney disease, emphasizing the bidirectional relationship between renal and cardiovascular health. Experts will discuss strategies for risk assessment and management in affected populations.
05 Hypertension-Related Kidney Disease: Epidemiology and Trends +
This track will present epidemiological studies that investigate the prevalence and trends of hypertension-related kidney disease globally. Researchers will share insights on demographic factors, risk stratification, and public health implications.
06 Patient-Centered Approaches to Kidney Disease Management +
This session will focus on the importance of patient engagement and education in the management of hypertensive kidney disease. Presentations will cover strategies for improving adherence to treatment and enhancing patient outcomes.
07 The Role of Nutrition in Hypertensive Kidney Disease +
This track will explore the impact of dietary interventions on hypertension and kidney health. Experts will discuss the role of specific nutrients, dietary patterns, and the importance of personalized nutrition in managing kidney disease.
08 Pharmacotherapy in Hypertensive Kidney Disease +
This session will review current pharmacological treatments for managing hypertension in patients with kidney disease. Discussions will include the efficacy, safety, and potential side effects of various antihypertensive agents.
09 Emerging Biomarkers in Hypertensive Kidney Disease +
Participants will examine the potential of novel biomarkers for early detection and monitoring of hypertensive kidney disease. The session will highlight research on genetic, proteomic, and metabolomic approaches.
10 Integrative Approaches to Hypertensive Kidney Disease Management +
This track will focus on integrative strategies that combine conventional and complementary therapies for managing hypertensive kidney disease. Experts will discuss the evidence base for these approaches and their potential benefits.
11 Future Directions in Hypertensive Kidney Disease Research +
This session will provide a platform for discussing future research priorities and innovative approaches in the field of hypertensive kidney disease. Participants will explore potential collaborations and funding opportunities to advance the field.